GlobeNewsWire · HCM · November 1, 2026

HUTCHMED Announces Regulatory Filings Accepted for Review for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer in Europe and Japan

Get the app for more

Explore stock news, insights and company research.